Chelation involves the intravenous administration of a “chelating agent”, such as ethylenediaminetetraacetic acid (EDTA), the most common and safe agent. Chelating agents such as EDTA enter the bloodstream and latch onto heavy or toxic metals (such as mercury, arsenic, aluminum, lead, iron, and cadmium) that build up in human tissue. By binding to these heavy metals and carrying them out of the body, this process reduces the body’s toxic metal burden and helps slow and reverse many chronic conditions such as atherosclerosis.
 

Because the aging process itself correlates with ongoing free radical damage, it is no surprise that a large variety of symptoms have been reported to improve following chelation therapy, even symptoms not directly caused by a circulatory disease. Patients generally feel younger and more energetic following therapy, even when taken for purely preventive reasons. In fact, chelation therapy is more desirable as a preventative measure than it is for the treatment of disease. Preventive medicine is always preferable to late-stage crisis intervention.